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The octahedral rhenium cluster compound Na2H8[{Re6Se8}(P(C2H4CONH2)(C2H4COO)2)6] has recently
emerged as a very promising X-ray contrast agent for biomedical applications. However, the synthesis of
this compound is rather challenging due to the diﬃculty in controlling the hydrolysis of the initial
P(C2H4CN)3 ligand during the reaction process. Therefore, in this report we compare the in vitro and
in vivo toxicity of Na2H8[{Re6Se8}(P(C2H4CONH2)(C2H4COO)2)6] with those of related compounds featur-
ing the fully hydrolysed form of the phosphine ligand, namely Na2H14[{Re6Q8}(P(C2H4COO)3)6] (Q = S or
Se). Our results demonstrate that the cytotoxicity and acute in vivo toxicity of the complex
Na2H8[{Re6Se8}(P(C2H4CONH2)(C2H4COO)2)6] solutions were considerably lower than those of com-
pounds with the fully hydrolysed ligand P(C2H4COOH)3. Such behavior can be explained by the higher
osmolality of Na2H14[{Re6Q8}(P(C2H4COO)3)6] versus Na2H8[{Re6Se8}(P(C2H4CONH2)(C2H4COO)2)6].
Introduction
Recent studies indicate that hexanuclear rhenium cluster
complexes with the general formula [{Re6Q8}L6] (where Q is
S, Se, or Te and Ls are some organic or inorganic apical
ligands) have high potential for therapeutic and diagnostic
applications in diﬀerent fields of biology and medicine due to
their luminescence, photosensitising and antitumor properties
as well as due to highly eﬃcient absorption of X-rays.1–13 This
set of outstanding physical properties led to intensive studies
of the biological properties of rhenium octahedral clusters.
As an example, we have recently developed the cluster complex
Na2H8[{Re6Se8}(P(C2H4CONH2)(C2H4COO)2)6] that demon-
strated high radiodensity and high water solubility.9
Importantly, our in vitro studies have shown that this com-
pound has low cytotoxicity as it does not internalise into cells.
In vivo studies have further confirmed low acute toxicity and
the rapid elimination of the compound from the body through
the urinary tract after intravenous injection.9,11 This com-
pound has therefore excellent potential for application as an
X-ray contrast agent.
This compound is synthesised under hydrothermal con-
ditions from tris-(2-cyanoethyl)phosphine (P(C2H4CN)3) and
Na4[{Re6Se8}(OH)6], upon which the organic ligand precursor
undergoes hydrolysis. Unfortunately, under these operating
conditions, it is diﬃcult to control the hydrolysis of
P(C2H4CN)3 and reproducibly obtain only two of three nitrile
groups for each ligand being hydrolysed to form a carboxylate
and one to form an amide. However, we have noticed that a
similar hydrothermal reaction between [{Re6Q8}(OH)6]
4− (Q = S
or Se) and P(C2H4COOH)3 carried out in aqueous solutions led
to the formation of the corresponding rhenium cluster
complexes having tris-(2-carboxyethyl)phosphines as ligands –
Na2H14[{Re6Q8}(P(C2H4COO)3)6]. Moreover, these compounds
can also be obtained directly from P(C2H4COOH)·HCl
and Na4[{Re6Q8}(OH)6] with high purity and good yield.
14
Therefore, in this report we compare the biological properties
of compounds Na2H14[{Re6Q8}(P(C2H4COO)3)6] (Q = S (1) or
Se (2)) in vitro and in vivo with those of closely related
Na2H8[{Re6Se8}(P(C2H4CONH2)(C2H4COO)2)6] (3) in order to
evaluate what eﬀect (if any) the level of hydrolysis and the
cluster core composition (i.e. {Re6S8}
2+ vs. {Re6Se8}
2+) has on
cellular internalisation and toxicity, and acute toxicity.
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Results
The critical step in the evaluation of the biological properties
of compounds (1), (2) and (3) is the determination of their
cytotoxicity. The eﬀect of the cluster complexes on the meta-
bolic activity of the cells was determined using the MTT colori-
metric assay. We used three diﬀerent cell lines as models to
evaluate the toxic eﬀect of these compounds: two cancer cell
lines – human larynx carcinoma (Hep-2) and human epithe-
lioid cervix carcinoma cell line (HeLa) – and a normal cell line
– peritoneal macrophages (MPh). The Hep-2 and HeLa cells
were chosen since these cell lines have already been used for
the evaluation of the cytotoxicity of several hexanuclear
metal clusters and cluster containing materials8–11,15–18 and
therefore the results obtained allow for the comparison of
cytotoxicity between diﬀerent cluster based materials.
Macrophages are cells of the mononuclear phagocytic system
responsible for the clearance of pathogens and chemical com-
pounds by phagocytosis and pinocytosis and they are also
involved in inflammatory reactions.19,20 Finding a non-toxic
in vivo bioimaging agent for macrophages could provide
researchers with new tools to advance the evaluation of
disease (e.g. cardiovascular disease, in particular ischemia,
arthritis and other inflammation processes) and therapies.21,22
The results obtained by the MTT test in the concentration
range 0.0056–5.76 mM are presented in Fig. 1, while values of
the half maximal inhibitory concentration (IC50) are summar-
ised in Table 1. The data show that compound (2) has the
highest cytotoxic eﬀect, while compound (3) has the lowest
cytotoxic eﬀect on all three model cell lines. The MTT assay
also demonstrates that the peritoneal macrophages are notice-
ably more sensitive to (1) and (2) than HeLa and Hep-2 cells.
Finally, all three studied cluster complexes showed no suppres-
sive eﬀect on the cell viability at concentrations from 0.0056 to
0.18 mM.
Since octahedral rhenium cluster complexes demonstrate
luminescence in the red region, it is easy to monitor the cellu-
lar internalisation of these compounds using confocal
microscopy. Indeed, it has already been shown before that
compound (3) does not enter Hep-2 cells.11 Here we have
undertaken similar studies on Hep-2, HeLa and MPh cell lines
to evaluate whether there is any diﬀerence in both their intern-
alisation in healthy and cancerous cells and between cluster
complexes with diﬀerent cores and apical ligands. Fig. 2 shows
the representative confocal microscopy images of the cells
incubated with 0.18 mM solutions of (1)–(3) for 24 hours.
These images show that for both cancerous cell lines, there
was no uptake of any of the studied compounds (Fig. 2G–R),
while there is clear evidence of intense red photoluminescence
located in the cytoplasm of the macrophages (Fig. 2A–F).
Acute toxicity studies were undertaken on Balb/C mice, i.e.
the same mice strain that was used for the acute toxicity
studies of compound (3) before. The animals were randomly
split into 9 groups with 10 mice in each group and treated
intravenously using clusters (1) and (2) at doses 50, 150, 250
and 350 mg (Re) per kg or sham-injected with physiological
Fig. 1 Cell viability response of HeLa, Hep-2 and MPh cells using the
MTT assay for (1), (2) and (3).
Table 1 The IC50 of (1), (2) and (3) on the Hep-2, HeLa cells and perito-
neal macrophages determined by the MTT assay
Compound
IC50 values, mM
MPh HeLa Hep-2
(1) 1.27 ± 0.03 1.42 ± 0.07 1.80 ± 0.64
(2) 0.36 ± 0.06 0.82 ± 0.03 1.07 ± 0.08
(3) 1.72 ± 0.58 1.66 ± 0.14 5.60 ± 0.17
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saline. The survival rate of the mice after the treatment (Fig. 3)
shows no evidence of toxicity for doses up to 150 mg (Re) per kg
of the complexes (1) or (2). Within the groups that were
treated with 250 mg (Re) per kg of (1) and (2), 6 and 4 mice,
respectively, died within the first day. 350 mg (Re) per kg of both
clusters was the lethal dose for all ten mice in the group.
Finally, we have not observed any changes in the behavior of
any of the animals that survived the treatment in any of the
groups.
The median lethal dose (LD50) was determined to be
256 ± 25 mg (Re) per kg and 232 ± 24 mg (Re) per kg for the
complexes (1) and (2), respectively. The LD50 for complex (3)
was earlier found to be 4.67 ± 0.69 g kg−1,11 which corresponds
to 1.59 ± 0.23 g (Re) per kg. Thus, from all three compounds,
complex (3) is the least toxic for both in vitro and in vivo.
One of the factors that can significantly aﬀect the acute tox-
icity of such closely related compounds may be the osmolality
of their aqueous solutions. Therefore, we measured the osmol-
ality of the solutions of (1) and (2) in the same concentrations
that were used for treatment of mice (10, 30, 50, 70 mg (Re)
per mL) and compared the results with those of complex (3)
(Table 2).
Fig. 2 Confocal ﬂuorescence microscopy of peritoneal macrophages (A–F), HeLa (G–L) and Hep-2 (M–R) after incubation with (1), (2) and (3) for
24 hours. Red ﬂuorescence and merged (phase contrast and ﬂuorescence) images.
Table 2 The osmolality of aqueous solutions of the cluster complexes
(1), (2) and (3) at diﬀerent concentrations
Compound C, mg (Re) per mL C, mM Osmolality, mOsm kg−1
(1) 70 62.7 580 ± 1
50 44.8 398 ± 2
30 26.9 257 ± 4
10 9.0 96 ± 1
(2) 70 62.7 613 ± 5
50 44.8 425 ± 2
30 26.9 255 ± 1
10 9.0 99 ± 1
(3) 70 62.7 279 ± 2
50 44.8 198 ± 1
30 26.9 122 ± 1
10 9.0 51 ± 1
Fig. 3 Survival rate of mice injected intravenously with 0.1 mL of the
cluster complexes (1) or (2) at diﬀerent doses (n = 10).
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The solutions of the cluster complex (3) at all measured
concentrations showed osmolality lower than that of serum
(285 ± 10 mOsm kg−1). However, the solutions of the cluster
complexes (1) and (2) possessed an acceptable osmolality only
at the concentrations of 10 and 30 mg (Re) per mL. At concen-
trations of 50 and 70 mg (Re) per mL the osmolality of the
solutions was higher than the osmolality of serum.
Discussion
Compounds Na2H14[{Re6Q8}(P(C2H4COO)3)6], where Q = S (1)
and Se (2) are chemical derivatives of the compound
Na2H8[{Re6Se8}(P(C2H4CONH2)(C2H4COO)2)6] (3) that was
earlier proposed as a potentially good X-ray contrast agent.
Specifically, there are two major diﬀerences between com-
pounds (1), (2) and (3): (i) the overall charge of the cluster
anions of (1) and (2) is significantly higher than that of (3) due
to the chemical composition and charge of the organic ligand,
i.e. three anion P(C2H4COO)3
3− rather than two anion
P(C2H4CONH2)(C2H4COO)2
2− and (ii) the content of the cluster
core in (1) is diﬀerent from (2) and (3). To evaluate the eﬀect of
these diﬀerences in chemical composition on the biological
properties of the cluster complexes, we have studied cellular
toxicity and cellular internalisation using three diﬀerent cell
lines and acute toxicity in mice.
The results of the MTT assay have shown that compound
(3) is the least cytotoxic for both the cancerous cell lines HeLa
and Hep-2 cells and the healthy cell line MPh, while confocal
microscopy has revealed that HeLa and Hep-2 cells do not take
up any of the studied cluster complexes, while intense red
luminescence located in the cytoplasm was observed from
macrophages treated with the clusters. Thus, confocal
microscopy imaging confirms the uptake of the clusters by
MPh. The lack of uptake of the metal cluster by cancer cells is
easily explained by the high negative charge of the cluster
anion that prohibits cellular internalisation due to repulsive
force with the cellular membrane. On the other hand it was
already shown that macrophages are eﬃcient in the uptake of
both positively and negatively charged particles.23,24
Macrophages are cells of the mononuclear phagocytic system,
which are distributed extensively in the tissue and play an
important anti-inflammatory role. Cellular inflammation is
one of the major symptoms of many developing pathologies
including atherosclerosis, type 2 diabetes, Alzheimer’s disease,
cancer and other illnesses.25–28 One of the main approaches
currently used for the detection and imaging of inflammation
is based on the CT visualisation of hard tissue. X-ray imaging
based on the use of radiopaque agents accumulated selectively
in macrophages was recently oﬀered as an alternative method
for the detection of cellular inflammation in soft tissues.29–33
The ability of (1), (2) and (3) to easily accumulate in macro-
phages makes these moieties potentially good agents for the
visualisation of cellular inflammation.
According to our in vivo toxicity studies on Balb/C mice,
complex (3) is considerably less toxic than (1) and (2). Despite
this, all these compounds demonstrate similar cellular inter-
nalisation patterns and the diﬀerence in their cellular toxicity is
not significant. One of the possible explanations of the notice-
ably increased acute toxicity of (1) and (2) is the diﬀerence in
the osmolality of the cluster solutions caused by a significant
increase of the cluster anion charge, which consequently leads
to a higher number of ions in a solution. Indeed, variations of
plasma osmolality may interfere with the cell membrane polar-
isation or function and induce cell shape changes that may
also modify the behavior of blood cells.34,35 Moreover, an intra-
venous injection of a hyperosmolar solution may produce sig-
nificant changes in the acid–base equilibrium and the electro-
lyte concentrations,36 as well as increase the viscosity of the
blood, disrupt the hemodynamics and induce thrombosis. The
measured osmolality of the solutions (1) and (2) in the concen-
trations used for the treatment of mice was found to be about
two-fold higher than that of the equivalent solutions of (3)
and, apparently such an increase in osmolality was enough to
increase the acute intravenous toxicity (i.e. LD50 values) of the
cluster complexes (1) and (2) by the factor of ∼6 in comparison
with complex (3).
Experimental
Materials and methods
Neutral aquahydroxo complexes [{Re6Q8}(H2O)4(OH)2] (Q = S or
Se) were prepared according to a literature procedure.37
Na4[{Re6Q8}(OH)6] was obtained by the reaction of the corres-
ponding complex [{Re6Q8}(H2O)4(OH)2] with an aqueous solu-
tion of NaOH followed by precipitation of Na4[{Re6Q8}(OH)6]
with an excess of ethanol.9 Na2H8[{Re6Se8}(P(C2H4CONH2)
(C2H4COO)2)6] (3) was synthesised by the hydrothermal reac-
tion between Na4[{Re6Se8}(OH)6] and P(C2H4CN)3 (130 °C,
48 h) and purified by the method described before.9,11
Na2H14[{Re6Q8}(P(C2H4COO)3)6] (Q = S (1) or Se (2)) were syn-
thesised by the hydrothermal reaction between Na4[{Re6Se8}
(OH)6] and P(C2H4COOH)3·HCl (130 °C, 48 h) and purified by
the methods described before.14
Osmolality of complexes (1), (2) and (3)
The osmolalities of aqueous solutions (1)–(3) were measured
with a freezing point depression osmometer (OCKP-1, KIVI
Osmometry, Saint Petersburg, Russian Federation). Each point
was measured three times and the average value was
determined.
Cell culture
Mouse peritoneal macrophages (MPh) were obtained from
Balb/C mice weighing 20–22 g. Animals were euthanized by
cervical dislocation after a one week acclimation period (temp-
erature 23 ± 2 °C and humidity 60%, free access to water and
standard food). Mice were injected intraperitoneally with 3 mL
of phosphate buﬀer saline (PBS), then the peritoneal lavage
fluid was washed and the peritoneal macrophages were col-
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lected and seeded in appropriate plates ready for in vitro
experiments.
Human larynx carcinoma cell line (Hep-2) and human
epithelioid cervix carcinoma cell line (HeLa) were purchased
from the State Research Center of Virology and Biotechnology
VECTOR (Russian Federation).
All cells were cultured in Eagle’s Minimum Essential
Medium (MEM, pH = 7.4) supplemented with a 10% fetal
bovine serum (FBS) under a humidified atmosphere (5% CO2
and 95% air) at 37 °C.
MTT-assay
MPh, Hep-2 and HeLa cells were seeded into 96-well plates at
the concentration of 5–7 × 103 cells per well and incubated for
24 h under a 5% CO2 atmosphere at 37 °C. The cells were then
treated with solutions of (1), (2) and (3) taken in a broad range
of concentrations (from 0.0056 to 5.76 mM) and incubated for
72 h under the same conditions. MTT reagent was added to
each well to achieve a final concentration of 250 µg mL−1, and
the plates were incubated for 4 h. The formazan formed was
then dissolved in DMSO (100 μL). The optical density was
measured with a plate reader Multiskan FC (Thermo Scientific,
USA) at a wavelength of 570 nm. The experiment was repeated
three times on separate days.
Quantitative data obtained were analysed using Stastistica
10.0 (StatSoft). Analysis between groups for the MTT assay was
assessed by the Mann–Whitney U test. The p values <0.05 were
considered statistically significant.
Confocal fluorescence imaging
The cells were seeded on microscope slides at the concen-
tration of 1 × 105 cells per slide and incubated at 37 °C under a
5% CO2 atmosphere for 24 h. The culture medium was then
replaced for the culture medium containing 0.18 mmol of (1),
(2) and (3) and the cells were incubated for 24 h. The cells
were then washed with PBS and fixed in 4% paraformalde-
hyde. The cells were visualised using a Zeiss LSM 510 confocal
microscope (Carl Zeiss Inc., Jena, Germany) equipped with a
laser diode (405 nm) for fluorescence and with a 100× oil
immersion objective.
Animals and housing conditions
All animal procedures were carried out in accordance with the
protocols approved by the bio-ethics committee of Siberian
Branch of the Russian Academy of Sciences, recommendations
for proper use and care of laboratory animals (European
Communities Council Directive 86/609/CEE) and principles of
the Declaration of Helsinki. Mice were housed in stainless
steel cages containing sterile paddy husk as bedding in venti-
lated animal rooms with free access to water and a commercial
laboratory complete food. Animals were acclimatised for
1 week prior to the experimental use.
Median lethal dose assessment
Ninety 8-week-old Balb/C mice, each having a body weight of
20 ± 2 g, were randomised into 9 groups of 10 animals per
group (5 males and 5 females in each group) and received
intravenous injection in the tail vein of 0.1 mL of an aqueous
solution of the cluster complex (1) or (2) at doses 50, 150, 250
or 350 mg (Re) per kg, or sham-injected with the same volume
of physiological saline. The solutions for intravenous infusion
were used at the physiological pH = 7.4 that was achieved by
the addition of NaOH. The animals were regularly observed for
clinical signs and mortality for two weeks. After this period the
mice were sacrificed.
Conclusions
In conclusion, in vitro studies have shown that the cytotoxicity
and cellular internalisation behavior of complexes (1) and (2)
are comparable to those of the complex (3). However, due to
the increased osmolality of the complexes (1) and (2), their
intravenous acute toxicity in vivo is significantly higher. Thus
our study demonstrates that even a minor chemical change of
the ligand environment of the cluster that alters the overall
charge of the cluster anion can have a drastic eﬀect with
regard to the toxicity of the compound. Our study has also
demonstrated that in terms of toxicity and internalisation,
there is no significant diﬀerence between {Re6S8}
2+ and
{Re6Se8}
2+. Moving forward, one way to produce highly
eﬀective X-ray contrast rhenium octahedral species of similar
chemical structures, but reduced acute toxicity would be the
esterification of all or some of the carboxylate groups of the
organic ligands to reduce the overall charge of the complexes.
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